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versus usual care for patients in non-
operative management - the CIPIC Rehab
Study: study protocol for a randomised
controlled trial
Maj Siercke1,2* , Lise Pyndt Jørgensen3, Malene Missel4, Lau Caspar Thygesen5, Pernille Peppercorn Blach6,
Henrik Sillesen1,2 and Selina Kikkenborg Berg2,7
Abstract
Introduction: Intermittent claudication (IC) caused by peripheral artery disease (PAD) is a common cardiovascular
disease. Patients with IC have reduced walking capacity, restricted activity levels and mobility, and reduced health-
related quality of life. The disease leads to social isolation, the risk of cardiovascular morbidity, and mortality. Non-
operative management of IC requires exercise therapy and studies show that supervised exercise training is more
effective than unsupervised training, yet many patients with IC lack motivation for changes in health behaviour.
No studies investigating the effects of existing cardiac rehabilitation targeted patients with IC have been published.
The aim of this article is to present the rationale and design of the CIPIC Rehab Study, which examines the effect of
a cross-sectoral rehabilitation programme versus usual care for patients in non-operative management for IC.
Methods and analysis: A randomised clinical trial aims to investigate whether cardiac rehabilitation for patients
with IC in non-operative management versus usual care is superior to treatment as usual. The trial will allocate 118
patients, with a 1:1 individual randomisation to either the intervention or control group.
The primary outcome is maximal walking distance measured by the standardised treadmill walking test. The
secondary outcome is pain-free walking distance measured by the standardised treadmill walking test, healthy diet
measured by a fat-fish-fruit-green score, and level of physical activity measured by an activity score within official
recommendations. Statistical analyses will be blinded.
Several exploratory analyses will be performed. A mixed-method design is used to evaluate qualitative and
quantitative findings. A qualitative and a survey-based complementary study will be undertaken to investigate
patients’ post-discharge experiences. A qualitative post-intervention study will explore experiences of participation
in rehabilitation.
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Discussion: The study is the first to assess the effect of a cardiac rehabilitation programme designed for patients
with IC. The study will describe how to monitor and improve rehabilitation programmes for patients with IC in a
real-world setting. Mixed-method strategies can allow for both exploration and generalisation in the same study,
but the research design is a complex intervention and any effects found cannot be awarded a specific component.
Trial Registration: Retrospectively registered in Clinicaltrials.gov identifier: NCT03730623.
Keywords: Intermittent claudication, Cross-sectoral rehabilitation, Physical exercise,
Background
Peripheral artery disease (PAD) is a chronic occlusive ar-
terial disease caused by progressive atherosclerosis [1].
The most common symptom is intermittent claudication
(IC), defined as a cramping leg pain that occurs during
walking and is relieved by a short period of rest. IC af-
fects 2% of the population (age 50–60) and increases
with age to 6–7% (age 65–75) of the population in
Western Europe and the USA [2]. Patients with IC have
diminished walking capacity, restricted activity levels
and mobility, and reduced health-related quality of life
[3, 4]. It leads to social isolation and, unless health be-
haviour and relevant medications are prescribed, it may
lead to worsening of disease with the risk of atheroscler-
otic complications and death [1, 3–8]. Motivation is an
important but neglected factor as studies indicate that
many patients with IC are not motivated for health be-
haviour changes in accordance with current recommen-
dations [6, 7, 9]. Due to the risk of complications and
limited patency of revascularisation (depending on pro-
cedure and anatomic location), current guidelines rec-
ommend that patients not requiring surgical
revascularisation due to critical limp ischaemia be man-
aged conservatively without surgical intervention [10].
Current practice for managing IC in Danish hospital set-
tings involves brief advice to ‘stop smoking and keep
walking’, combined with preventive medications includ-
ing cholesterol-lowering treatment with statins and anti-
platelet therapy [10, 11]. Non-adherence to these
recommendations increases the risk of progression from
IC to critical ischaemia and limb amputation [1]. It also
produces a substantial economic burden on society due
to reduced working ability, hospitalisation, and associ-
ated personal and social consequences for the individual
patient [12, 13]. A recent Cochrane review [14] con-
cluded that for patients with IC exercise is important re-
gardless of whether treatment is revascularisation or
overall conservative management. Supervised exercise
training (SET) programmes are effective for alleviating
symptoms, increasing walking distance, reducing cardio-
vascular risk factors and improving quality of life. Add-
itionally, SET is relatively inexpensive and cost-efficient
compared with other more invasive therapies [13–16].
Although evidence for SET is strong, studies exploring
the effects of cross-sectoral rehabilitation intervention
on patients treated for IC are lacking. IC rehabilitation is
still poorly implemented and knowledge about how to
set up an effective programme in a community-based
setting is poor [17, 18].
Rehabilitation
Secondary prevention initiatives including rehabilitation
for patients with PAD are recommended in current
guidelines [5, 19]. Community-based supervised exercise
appears to be at least as effective as exercise pro-
grammes provided in hospital settings [20]. Importantly,
a study recently reported that attending a hospital-based
supervised exercise programme was difficult for patients
due to time spent on transportation and logistics [21].
This indicates that intervention in the local community
improves patients’ motivation and adherence [22].
Therefore, given the evidence for the beneficial effect of
supervised exercise training for patients after acute cor-
onary syndrome, the hypothesis is that patients with IC
could also benefit with regard to maximal walking dis-
tance (MWD), pain-free walking distance (PWD),
health-related quality of life, and physical function. Pa-
tients' perspectives on participating in the intervention
could shed light on the factors that facilitate or hinder
exercise and recommended health behaviour. Knowledge
of this may increase both the quality and patient adher-
ence to the conservative management of IC, thereby at-
tenuating the burden of disease and improving quality of
life for patients with IC.
Study objectives
The objectives of the trial are to investigate the effects of a
cross-sectoral exercise and lifestyle intervention based on
the established rehabilitation programme for patients with
ischaemic heart disease versus usual care without rehabili-
tation in patients with IC. The primary hypothesis is that,
compared with the control group, a specialised rehabilita-
tion programme for the intervention group improves
MWD in the treadmill walking test after the completed
intervention. The three secondary hypotheses are that
PWD, diet and level of physical activity improve in the
intervention group compared with the control group after
6 and 12months. Exploratory analyses will test the
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hypothesis that IC rehabilitation improves quality of life,
health behaviour, physical activity and reduces anxiety and
depression after 6 and 12months. The effects, benefits,
and motivational factors of conservative management will
be examined and patient experiences of the intervention,
including factors that support or hinder adherence to the
intervention explored.
Design
The CIPIC Rehab Study is designed to develop
evidence-based knowledge on rehabilitation among pa-
tients with IC. It is a cross-sectoral, multidisciplinary,
randomised clinical trial designed to examine the effects
of an IC rehabilitation programme compared with usual
care for patients in non-operative treatment for IC. Ac-
cordingly, the trial combines quantitative and qualitative
research methods. The mixed methods are integrated by
applying the explanatory sequential design [23, 24]. The
rationale for this approach is that the quantitative find-
ings provide a general understanding of the research
problem through statistical results, and qualitative find-
ings refine and explain the results by exploring partici-
pants’ views in greater detail. Qualitative research
coupled with randomised controlled trials can contribute
to developing and evaluating complex healthcare inter-
ventions; it may be particularly useful in evaluating in-
terventions that involve social and behavioural processes
that are difficult to explore or capture using quantitative
methods alone [25, 26]. A pragmatic world view is the
philosophy underpinning the study [23].
Study population and eligibility criteria
Consecutive patients at the Department of Vascular Sur-
gery at the Rigshospitalet in Copenhagen, Denmark will
be screened for inclusion and approached for study
participation.
Inclusion criteria are: patients with newly diagnosed
IC treated conservatively; age > 18 years; speak and
understand Danish; able to provide informed written
content; citizens of the eight municipalities of Greater
Copenhagen belonging to the Healthcare Centre; and
able to perform physical exercise. Exclusion criteria are:
failure to understand and cooperate according to the
trial instructions; co-morbidity complicating physical ac-
tivity and exercise training, and lack of informed
content.
Study procedure
When the informed content is signed, baseline data will
be collected including a questionnaire administrated by
the primary investigator. After baseline data collection,
randomisation is conducted. Computer-generated block
randomisation in four blocks has been done by an inde-
pendent statistician and delivered in envelopes blinded
from investigators. Randomisation is conducted by on-
going inclusion numbers marked on the envelopes.
Control group – usual care
Patients randomised to the control group will initially
receive the department’s usual, brief advice about exer-
cise therapy (walking), smoking cessation, and preventive
medical treatment with antiplatelet therapy and statins.
The IC patients will receive written information about
medication, walking exercise, and a logbook for self-
reporting of walking behaviour in the outpatient clinic at
the Department of Vascular Surgery, Rigshospitalet. Pa-
tients in the control group will follow standard follow-
up procedure for patients treated for IC.
Experimental intervention group
The intervention group initially receives the usual care
in the outpatient clinic at the Department of Vascular
Surgery; additionally, patients’ home communities offer
courses in smoking cessation. Patients will receive a ped-
ometer and be asked to self-report walking behaviour
and steps in a logbook. The patient brings the logbook
to the consultation with the physiotherapist, who initi-
ates the startup training, supplies the motivation and ex-
plains the goal for the physical activity. Patients in the
intervention group will follow the specialised cardiac re-
habilitation programme for patients with IC. The inter-
vention is based on experiences of cardiac rehabilitation
and guidelines of the Danish National Board of Health
and European Society of Cardiology [19]. Theories about
personalised feedback and self-efficacy will be used as a
method for encouraging behavioural changes to improve
health outcomes [27].
Physical exercise training component
Training sessions will take place at a Healthcare Centre
within the municipality of Greater Copenhagen. The
main goal of the exercise is to improve the patient’s
physical capacity and health behaviour, such that this
subsequently results in physical and psychological health
benefits. Supervised exercise training is also targeted, re-
lieving the fear and uncertainty the patient may feel to-
wards physical activity. Two specialised cardiac
rehabilitation physiotherapists with specific insight into
IC will plan and supervise participants’ exercise. This en-
tails patients actively engaging, in groups with up to ten
in 24 supervised physical exercise sessions, each lasting
one hour with two weekly sessions. The exercises in-
clude varied forms of physical exercise all combined to
accommodate the patients’ own goals regarding walking
distance. The physiotherapists will administer and rec-
ord a six-minute walking test and 30-second chair stand
test prior to and at completion of the intervention. Ped-
ometer and self-reported walking behaviour are a part of
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the consultation used to increase or sustain daily phys-
ical exercise at least 30 minutes per day. The results will
be used as part of an individual motivational interview
with each patient after completion of the 24 training
sessions.
Supervised exercise training programme
The exercise training protocol will consist of a 10–15-
minute warm-up, followed up by a 45–50-minute com-
bination of strength and circuit training. The exercise
training programme is based on national guidelines for
cardiac rehabilitation [28]. The warm-up will be based
on either bicycling, with a focus on using the forefoot
when pedalling, or walking in different variations, i.e.
walking on toes, heels, walking sideways, walking lunges
and walking at different paces. In strengthening the large
muscle groups, there will be a primary focus on the leg
muscles. The strength exercises for the upper body will
primarily be performed as an intermission, in the exer-
cise for the lower body. Different exercise equipment
will be used to create resistance in the exercise training,
i.e. elastic bands, body bars, dumb bells, and strength-
training machines. The exercise will vary from 1 × 15,
2 × 15, and 3 × 10 repetitions, based on low to moderate
intensity of 40–60% of the maximum muscle strength
[28]. The circuit training will primarily be based on ac-
tivity for the lower limbs, i.e. walking and running at dif-
ferent paces and variations, walking combined with an
exercise, i.e. high knee lifts, kick backs, calf raises, and
different relay races in teams. The circuit training will
also involve interval training, of varying lengths, depend-
ing on both the different exercises and the patients’ indi-
vidual limits due to lower limb pain. Two of the sessions
will be based on using and practising pole striding at a
nearby outdoor training park. In addition to the physical
activity component, the programme will also contain
components of health education for improving the self-
efficacy of physical activity in the patients and therefore
seek to affect health behaviour. Five of the sessions will
contain 10–15minutes of health education, which will
include the use of tools developed by Steno Diabetes
Center, Copenhagen, Denmark. These tools were devel-
oped for supporting patients in making long-term
health-related changes, and for the use of health profes-
sionals in health education for patients with chronic ill-
ness [29]. Furthermore, the health education will contain
motivational, group-based dialogue with the patients
about their health behaviour and ability to participate in
physical activity in their own neighbourhood. There will
also be motivational conversations concerning the pa-
tients’ daily use of and achievements with the pedometer
and logbook handed out to each patient at the start of
the intervention.
Education in groups and individual consultation
The aim of the intervention is to provide emotional sup-
port, improve coping skills, and to respond to physical
symptoms. Education and information about the disease
prepares the patient for expected symptoms and sensa-
tions, and dialogue and shared reflections facilitate strat-
egies for coping with symptoms and experiences
associated with the condition, for example when leg pain
is part of the treatment for getting better. The group
education is a two-hour-long session, about the patho-
physiology of IC, medications, health behaviour, disease
management, quality of life, and coping with the disease.
The principal investigator (MS), who is an experienced
cardiac rehabilitation nurse with specific knowledge of
IC to ensure protocol compliance, will perform the
intervention. Information given will also be based on na-
tional guidelines and standard treatment of patients with
IC. A clinical dietician will advise participants in a two-
hour-long group session about healthy diet and athero-
sclerosis, and in addition give access to individual
consultation.
Albert Bandura’s Social Cognitive-Behavioral Theory
and self-efficacy inspires the intervention. Its focus is on
the dynamic interaction of person and behaviour; the in-
dividual’s actual ability to perform the appropriate be-
haviour; learning a new skill or knowledge by observing
others; external responses to the individual’s behaviour
that either encourage or discourage the behaviour expec-
tations: the anticipated consequences of a behaviour;
and self-efficacy: the person’s confidence in his or her
ability to perform a behaviour [27, 30]. Consequently,
the individual, the group, spouses, and surroundings in a
rehabilitation setting are important. Spouses are there-
fore invited to participate in group sessions as well as in
individual sessions.
Studies show that text messages can facilitate lifestyle
changes [31–33]. After completion of exercise training,
participants are offered personalised motivational
follow-up text messages. The content, frequency, and
duration of the text messages are agreed upon individu-
ally for the next 8 months and will be reassessed at
follow-ups after 3 and 6 months.
Outcomes and data collection
Data will be collected at admission, discharge, 6 months
and 12 months administrated by the primary investigator
(see Table 1). The primary and the secondary outcomes
reflect the primary modifiable factors of the intervention,
and a number of explorative outcomes will be collected
to evaluate the effect and meaning of the intervention
(see Table 2). The post-discharge experiences of patients
in the intervention group will be explored through semi-
structured qualitative interviews. Patient flow is illus-
trated in Fig. 1.
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Primary outcome
MWD will be measured by the standardised treadmill
walking test based on a graded protocol (3.2 km/hour
with 2% increase every 2 minutes). Treadmill assessment
has the highest reliability when using a graded protocol
together with outcome measurements, such as initial
claudication distance and absolute claudication distance.
Results of treadmill testing are expressed as the initial
claudication distance, the moment claudication pain be-
gins and the absolute claudication distance, the moment
the test has to stop due to the maximal level of bearable
claudication pain [36, 37]. The follow-up treadmill walk-
ing test will be performed by a research assistant blinded
as to the patients’ group affiliations.
Secondary outcome
PWD will be measured by the standardised treadmill
walking test as described above and with a numeric rating
scale for pain [37, 43]. Daily physical activity is measured
by self-reported number of times per week of walking or
physical exercise activity of at least 30minutes, as recom-
mended by the National Board of Health [44]. Diet will be
measured by a diet questionnaire (HjerteKost), a validated
Danish instrument with 19 items. The scale offers two
scores, a fat and a fish-fruit-green score, each of which
can range from 0 to 18. To be able to achieve the term
‘healthy’ the score must be at least 75% in both the fat and
the green scores [35]. The instrument is validated and rec-
ommended by the National Board of Health [28].
Exploratory outcomes
Smoking is measured by self-reported smoking behav-
iour by the Fagerström Test for Nicotine Dependence.
The self-administered questionnaire has good internal
validity and a good correlation with nicotine levels as an
instrument for measuring addiction to tobacco [45].
Table 1 The CIPIC Rehab Study - exploratory quantities subjected to post hoc analysis
Quantity Time of measure Type of quantity
Demographic
Sex Baseline Binary (M/F)
Age, height, weight, body mass index (BMI) Baseline Continuous
Marital, occupational, educational status Baseline Categorical
Clinical
Charlson Comorbidity Index [34] Baseline, 6, 12 Categorical
Hypertension Baseline 6, 12 Binary (Y/N)
Smoking+ Fagerströms test, (Alcohol Timeline
Followback)
Baseline, 6, 12 Categorical
Medication (routine drugs; antiplatelet; statins
and other medication)
Baseline, 6, 12 Categorical
Nutritional screening ‘HjerteKost’: fat-fish-fruit-
green score [35]
Baseline, 6, 12 Categorical
Paraclinical
Blood work (biomarkers, cholesterol, HBa1C,
Hg, thyroid)
Baseline, 6, 12 Continuous
Physical function
The standardised treadmill walking test [36, 37] Baseline, 6, 12 Continuous
Six-minute walking test (before and after supervised
exercise training) [38]
Baseline, 3 Continuous
Sit to stand test (before and after supervised exercise
training) [39]
Baseline, 3 Continuous
Level of physical activity (0–7 times a week) Baseline, 6, 12 Categorical
Questionnaires
HADS, Hospital Anxiety and Depression Scale [40] Baseline, 6, 12 Categorical
VascuQol, Vascular Quality of Life questionnaire [41] Baseline, 6, 12 Categorical
PAM13, 13-item Patient Activation Measure [42] Baseline, 6, 12 Categorical
Pedometer, text message (intervention group) 3 months, 6 Binary (Y/N)
Participation in dietician and nurse session
(intervention group)
3 months Binary (Y/N)
M/F male/female, Y/N yes/no
Siercke et al. Trials          (2020) 21:105 Page 5 of 10
Alcohol consumption will be measured by the Alcohol
Timeline Followback (TLFB). TLFB has been shown to
be a psychometrically sound assessment instrument for
obtaining retrospective daily estimates of alcohol con-
sumption. TLFB has been extensively evaluated in vari-
ous settings, over varying reporting intervals and with
diverse drinker populations and has been found to have
very good measurement properties [46, 47].
The Hospital Anxiety and Depression Scale (HADS)
HADS is a 14-item instrument that measures symptoms
of anxiety (HADS-A) and depression (HADS-D). The
scale offers two subscales, each of which can range from
0 to 21. Scores of 0–7 for either subscale are regarded as
normal; 8–10 suggest the presence of a mood disorder;
and 11 and above suggest the probable presence of a
mood disorder. This tool has been translated and vali-
dated in many countries and its capacity to detect anx-
iety and depressive disorders is widely recognised [48].
The Vascular Quality of Life questionnaire (VascuQoL)
VascuQoL (VQ6) is a PAD-specific instrument recom-
mended as one of the preferred questionnaires when
evaluating quality of life outcomes in patients with PAD.
The VQ6 is a six-item questionnaire, developed using a
Table 2 Focus group - interview topics
Supervised exercise training: physiotherapist. Content and education
Education session: nurse and dietician. Content and education
Patients’ experiences of participating in the intervention group.
Knowledge and uncertainty about IC
Experiences of factors and barrier that supported or hindered
adherence to the intervention.
Factors that influence coping strategy, persistent lifestyle changes
Importance of environment and togetherness with similar patients
Empathy, support and motivation
Risk factor management
Coping behaviours
Change interventions
Attitudes, beliefs, how to handle the pain
Feeling better mentally
Accessibility and compliance
Self-monitoring goal setting
Exercise logbook and pedometers. Motivational text message.
Specific walking advice to promote self-managed walking
Quality of life
Solution behaviour change techniques
Patient satisfaction of participate in the IC rehabilitation
programme and point out if any suggestions for changes.
Fig. 1. Patient flow
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combination of qualitative and quantitative method-
ology. The VQ6 has acceptable to good psychometric
properties regarding data quality, scale assumptions, tar-
geting, validity and reliability. Further, VQ6 seems to be
easy to use and comprehend within the target popula-
tion of patients with PAD [41].
The Patient Activation Measure (PAM)
PAM-13 is a 13-item instrument for evaluating educa-
tional interventions aimed at improving patient engage-
ment. Patient activation specifies the level of patients’
engagement and may contribute to better self-
management, higher engagement in treatment and
greater patient satisfaction. The European translations of
PAM-13 resulted in four instruments with good psycho-
metric capabilities for measuring patient activation. All
items have five possible responses with scores ranging
from 0 to 4: (1) disagree strongly, (2) disagree, (3) agree,
(4) agree strongly or (0) not applicable [42, 49].
Complementary studies
Numerous data will be collected to evaluate the effect
and meaning of the intervention.
Quantitative data
The quantitative study consists of an individual ques-
tionnaire survey conducted as interview by the principal
investigator. The survey including data about feasibility:
participation (number of times), use of pedometer (yes/
no), logbook (yes/no) and to what extent it has moti-
vated daily physical exercise, exercise choice after the
course, and text messages (yes/no). Results from the
physiotherapist six-minute walking test and 30-second
chair stand test, before and after in metres/number are
also included.
Qualitative explorative data
As a part of the study, brief individual interviews explor-
ing course satisfaction, suggestions for changes, and the
relevancy of the various rehabilitation components will
be conducted. Furthermore, focus group interviews of
patients participating in the intervention group will also
be conducted. Prior to interviewing, an interview guide
will be developed. It will be used to help explore patient
experiences of training and teaching sessions, factors
helping or hindering improvement in health behaviour,
the use of the pedometer, logbook, and text message in-
fluenced motivation/adherence, patient satisfaction with
the intervention and suggestions for future rehabilitation
programmes. Research questions will be developed using
knowledge from existing qualitative studies in the field
and the individual brief interviews [6, 7, 9, 15, 17, 50, 51]
(see Table 2). The focus group interviews will be con-
ducted by the principal investigator (MS) and two
assistant moderators that register key points and takes
field notes [52]. Patients will be recruited during their 3-
and 6-month follow-ups at the Healthcare Centre or at
the Department of Vascular Surgery as a convenience
sampling with consecutive recruitment of participants ac-
cording to the groups in which they exercised during the
training sessions. To embrace the potential impact of any
team spirit developed during the training session, we con-
sider focus groups and recruitment of participants accord-
ing to training groups to be relevant. The interviews will
be held in well-known surroundings in the Healthcare
Centre. The size of the focus groups will be five to eight
participants to secure an opportunity for each person to
share insights, experiences and observations. Smaller
groups allow more in-depth conversation and afford each
person a greater opportunity to speak. ‘Information power’
will guide the adequate sample size and the number of
focus group interviews [52].
Data collection and data analysis
The interviews will be audio recorded and transcribed
verbatim. Interviews are anticipated to last approxi-
mately one hour. Thematic analysis according to Braun
& Clarke will be used to analyse data [53]. This means
combining a coding analysis with the content of the
focus group discussion [11, 13]. Derivation of themes
will be identified by an exploratory analysis to present
selected patterns relevant for the study aim and collected
data. Numbers of data coders, description of the coding
tree, software program, illustrated themes/findings,
quotation identification, consistency between the data
presented and the findings, as well as the clarity of major
and minor findings will be a part of the analysis [54, 55].
The thematic analysis will be used as a systematic ap-
proach to the analysis of quality data from the focus
group interviews. That involves identifying themes or
patterns of meaning by coding and classifying data text-
ually, according to themes and interpreting the resulting
thematic structures by seeking commonalties, relation-
ships, overarching patterns, theoretical constructs, or ex-
planatory principles [56].
Statistical analysis
A trial-independent statistician will make a blind ana-
lysis of the data and the primary and secondary analyses
will be performed according to the intention-to-treat
principle. We will use general regression models for the
continuous outcomes and logistic regression models for
binary outcomes. In the analysis of the primary outcome,
the outcome (MWD at 6 months) will be analysed with
adjustment for baseline MWD, sex or age (included con-
tinuously). For the three secondary outcomes – PWD
distance, level of physical activity and diet at 6 months –
the analysis will be done similarly with adjustment for
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baseline values, sex and age (continuous). As exploratory
analyses of MWD, PWD, smoking behaviour, diet and
patient-related outcome measures, mixed general and
generalised models with repeated measurements will be
used including measurements at baseline, 6 and 12
months in the same model. These models will also be
used for all other explorative outcomes. In these models,
the interaction between intervention group and time is
of primary interest, indicating different developments
after intervention start. In the case of significant results
in the primary outcome, sensitivity analyses will be per-
formed to estimate the potential effect of data missing at
random by a worst-case scenario. Let X be the group
where a beneficial effect is observed, and Y be the other
group. Missing values in group X will be imputed by the
minimum value found in the material and missing values
in group Y will be imputed by the maximum value
found. The primary outcome will be tested first using a
significance level of 0.05. Analyses of the secondary and
exploratory outcome measures as planned above will be
analyzed with no p value adjustment due to multiplicity.
Instead, the interpretation of these results will be
assessed in the light of multiple testing, i.e. statistically
significant effects will be interpreted in the context of in-
creased risk of type I error. The clinical effect size will
be reported by Cohen’s d. Per protocol analyses of the
primary and secondary outcomes will be performed.
Sample size and power calculation
The expected average baseline value of MWD has been
set to 120m with a detected 50% improvement (60m).
There is a wide variance in MWD in this patient group
and consequently the standard deviation (SD) is set at
100m, based on an expected improvement in walking
ability of approximately 50% to 200% [18]. With a 5% sig-
nificance level and 80% power, it will thus be necessary to
include 88 patients to detect an improvement of 60m in
MWD in the intervention group at the 12-month follow-
ups, compared with the control group. Owing to the pre-
viously mentioned risk of co-morbidities, combined with
an expected drop-out, a drop-out of 25% must be ex-
pected, therefore the investigators plan to include 118 pa-
tients in total (59 in each group).
Discussion
This randomised clinical trial is the first to examine the
effect of a cross-sectoral exercise and health behaviour
intervention based on the established cardiac rehabilita-
tion programme for patients with IC. The CIPIC Rehab
Study will provide evidence on the rehabilitation needs
of patients treated conservatively for IC, ánd insight into
the patient benefits and motivational factors of conserva-
tive management experiences of the intervention. The
results can be used to make recommendations for a
specialised IC rehabilitation programme, which health-
care professionals and policymakers may use to make
qualified, evidence-based decisions in everyday clinical
practice and as a foundation for national and inter-
national guidelines. With a positive outcome, some of
the possible effects could be lower morbidity and a de-
crease in the use of the public health system. This is ad-
vantageous for both patients and society. Whether it
produces neutral, negative or positive results the study
will have implications for clinical practice and follow-up
care for patients treated for IC. The study has been de-
signed to meet the criteria for high quality in non-
pharmacological randomised clinical trials [57] with cen-
tral randomisation, blinded assessment of the exercise
outcome, and blinded analysis by a study-independent
statistician. Detailed information on the intervention re-
ceived and usual care will be collected, including self-
initiated exercise training during the trial period. The
secondary outcomes of self-rated mental health are sub-
jective by nature [58–60]. The trial is designed with mul-
tiple statistical comparisons, therefore results of the
explorative analyses will be interpreted with caution.
Trial status
Recruitment began on 1 April 2017 and end of the 12-
month follow-up of all patients will be completed in
april 2020 in accordance to protocol number: H-
17004183/clinicaltrials.gov.
Inclusion was initiated on 5 December 2017 and com-
pleted in 28 June 2019. End of the 12-month follow-up
of all patients will be completed at the end of June 2020.
The results of the trial and complementary studies will
be published in relevant international peer-reviewed
journals. Authorship will be determined according to the
guidelines of the International Committee of Medical
Journal Editors.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13063-019-4032-x.
Additional file 1. SPIRIT 2013 checklist.
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